ROSEMONT, Ill. — Group, Inc. (the “Company” or “Proteintech”), a global life sciences company, today announced the appointment of Patrick Yount as Chief Financial Officer, effective October 26, 2026, and the promotion of Jeb Gaybrick to Vice President of Corporate Strategy and Investor Relations. These appointments strengthen the Company’s leadership team as it continues its […]

Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters’ instruments and consumables Leverages Waters’ unique ability to take an AI-directed experiment from the research bench into development and into Empower™ Software, carrying its audit trail as the molecule moves into downstream, regulated […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) today announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to the Danaher Board of Directors on October 9, 2026. Dr. Hershberg has also been appointed to the Company’s Science and Technology Committee. Alan G. Spoon will not stand for reelection at Danaher’s […]

Investment strengthens Bio-Techne’s global GMP manufacturing infrastructure for cell therapy applications New Bristol facility expands GMP small molecule production capacity and complements recent investments in North America Combined capabilities across Bristol, St. Paul and Minneapolis support customers from discovery through commercial manufacturing MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents […]

BOSTON — SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in prostate cancer patients. The […]

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina’s genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of […]

New facility expands Hudson’s space for product development and introduces a new customer demo lab CEO Werner Maas and other team members cut the ribbon during the grand opening ceremony Hudson Lab Automation, a global laboratory automation solutions provider, today announced the opening of its new headquarters in New Providence, New Jersey. The expanded facility […]

Amsbio has expanded its range of high-quality FFPE tissues and controls specifically designed to support biomarker discovery, histopathology, translational research and assay development. Although the tissue structure in FFPE samples is maintained for histological analysis, damage to the RNA incurred through the fixation, embedding, and storage processes advances with time and storage temperature. Sub-optimal tissue […]

New capillary electrophoresis instrument triples sample throughput for DNA laboratories using 5-, 6- or 8-dye chemistry for casework, database and paternity samples MADISON, Wis. — Promega Corporation has launched a 24-capillary model of the Spectrum CE System for DNA typing, including forensic analysis. Spectrum CE Systems are the only capillary electrophoresis (CE) instruments designed and […]

PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models MENLO PARK, Calif. and PARIS — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a collaboration to generate full-length RNA data that TychoBio will use to train models […]